High materiality8/10
BeOne Medicines price target raised to $420 from $418 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist raises ONC target to $420; posted price $365.21; further confirmation of upside.
- Truist raises ONC target to $420; price $365.21
Key facts
- 01
Target: $420
- 02
Posted price: $365.21
- 03
Analyst firm: Truist Financial
- 04
Analyst: Gregory Renza
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.